Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Abroad (travel likely)RecruitingPHASE2
Conditions
Melanoma · NSCLC · Hepatocellular Carcinoma · Urothelial Cancer · Gastric Adenocarcinoma · HNSCC · Esophageal Adenocarcinoma · Microsatellite Instability-High Solid Malignant Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Dan P Zandberg, MD)
Study leads
Dan P Zandberg
Principal Investigator
UPMC Hillman Cancer Center